TR200101841T2 - Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları - Google Patents
Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmalarıInfo
- Publication number
- TR200101841T2 TR200101841T2 TR2001/01841T TR200101841T TR200101841T2 TR 200101841 T2 TR200101841 T2 TR 200101841T2 TR 2001/01841 T TR2001/01841 T TR 2001/01841T TR 200101841 T TR200101841 T TR 200101841T TR 200101841 T2 TR200101841 T2 TR 200101841T2
- Authority
- TR
- Turkey
- Prior art keywords
- infections
- bisphosphonates
- prevent
- treat
- parasites
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/662—Phosphorus acids or esters thereof having P—C bonds, e.g. foscarnet, trichlorfon
- A61K31/663—Compounds having two or more phosphorus acid groups or esters thereof, e.g. clodronic acid, pamidronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Virology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Otolaryngology (AREA)
- Urology & Nephrology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- AIDS & HIV (AREA)
- Neurology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Obesity (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Söz konusu bulus genel formül (I)'e uygun bifosfonik asitlerin ve bunlarin türevlerinin, insanlarda ve hayvanlarda virüs, bakteri, mantar ya da parazitlerin sebep oldugu enfeksiyonlara karsi, gama delta-T hücreleri etkinliginin giderilmesi yoluyla gerçeklestirilen terapötik ve profilaktik uygulamalar ile ilgilidir.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19859668A DE19859668A1 (de) | 1998-06-24 | 1998-12-23 | Verwendung von Bisphosphonaten zur Prophylaxe und zur Behandlung von infektiösen Prozessen |
Publications (1)
Publication Number | Publication Date |
---|---|
TR200101841T2 true TR200101841T2 (tr) | 2001-12-21 |
Family
ID=7892389
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2001/01841T TR200101841T2 (tr) | 1998-12-23 | 1999-12-23 | Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları |
Country Status (19)
Country | Link |
---|---|
US (1) | US6696427B1 (tr) |
EP (1) | EP1140113B1 (tr) |
JP (1) | JP2002533385A (tr) |
CN (1) | CN1331597A (tr) |
AT (1) | ATE253368T1 (tr) |
AU (1) | AU754862B2 (tr) |
BR (1) | BR9916850A (tr) |
CA (1) | CA2356262A1 (tr) |
CZ (1) | CZ20012231A3 (tr) |
DK (1) | DK1140113T3 (tr) |
ES (1) | ES2205930T3 (tr) |
IL (1) | IL143469A0 (tr) |
IS (1) | IS5956A (tr) |
MX (1) | MXPA01006473A (tr) |
NO (1) | NO20013167L (tr) |
PL (1) | PL349438A1 (tr) |
PT (1) | PT1140113E (tr) |
TR (1) | TR200101841T2 (tr) |
WO (1) | WO2000038660A2 (tr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7758503B2 (en) * | 1997-01-27 | 2010-07-20 | Lynn Lawrence A | Microprocessor system for the analysis of physiologic and financial datasets |
PL196485B1 (pl) * | 2000-05-11 | 2008-01-31 | Inst Farmaceutyczny | Stała doustna kompozycja farmaceutyczna zawierająca aminową pochodną kwasu bisfosfonowego i sposób jej wytwarzania |
US20070025960A1 (en) * | 2003-05-16 | 2007-02-01 | University Of Maryland Biotechnology Institute | Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
WO2005023270A2 (en) * | 2003-09-09 | 2005-03-17 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Compositions and methods for use of antiviral drugs in the treatment of retroviral diseases resistant to nucleoside reverse transcriptase inhibitors |
US7358361B2 (en) * | 2004-10-08 | 2008-04-15 | The Board Of Trustees Of The University Of Illinois | Biophosphonate compounds and methods for bone resorption diseases, cancer, bone pain, immune disorders, and infectious diseases |
US8012949B2 (en) * | 2004-10-08 | 2011-09-06 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods with enhanced potency for multiple targets including FPPS, GGPPS, and DPPS |
CA2646334A1 (en) * | 2006-03-17 | 2007-09-27 | The Board Of Trustees Of The University Of Illinois | Bisphosphonate compounds and methods |
AU2010226428A1 (en) * | 2009-03-20 | 2011-10-20 | University Of Iowa Research Foundation | Prenylated bisphosphonates as anti-tuberculosis agents |
EP2289900A1 (en) * | 2009-08-26 | 2011-03-02 | Humboldt Universität zu Berlin | Bisphosphonates as inhibitors of acid sphingomyelinase |
US10532064B2 (en) * | 2014-08-12 | 2020-01-14 | The University Of Hong Kong | Biophosphonate compounds and gamma delta T cell-mediated therapy for treating epstein-barr virus-associated disorders |
WO2021207047A1 (en) * | 2020-04-06 | 2021-10-14 | Duke University | Compositions and methods for the treatment of infection-induced cardiomyopathy |
CN114223667B (zh) * | 2021-12-09 | 2023-04-07 | 沈阳农业大学 | 含氮双膦酸盐在抑制卵菌中的应用 |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE6921862U (de) | 1969-05-30 | 1969-09-18 | Emmrich & Schoening Gmbh Fa | Lampe |
US4820698A (en) | 1985-11-04 | 1989-04-11 | The Procter & Gamble Company | Antimicrobial agents and process for their manufacture |
EP0541037A3 (en) | 1991-11-06 | 1997-02-26 | Takeda Chemical Industries Ltd | Squalene synthetase inhibitory composition and use thereof |
US5270365A (en) * | 1991-12-17 | 1993-12-14 | Merck & Co., Inc. | Prevention and treatment of periodontal disease with alendronate |
US5441946A (en) * | 1994-04-14 | 1995-08-15 | Rhone-Poulenc-Rorer Pharmaceuticals, Inc. | Phosphonate derivatives of lipophilic amines |
US5652227A (en) | 1995-01-30 | 1997-07-29 | Teronen; Olli Pekka | Inhibition of the degradation of connective tissue matrix protein components in mammals |
GB9607945D0 (en) | 1996-04-17 | 1996-06-19 | Univ Nottingham | Bisphosponates as Anti-inflammatory agents |
WO1997043437A2 (en) | 1996-05-15 | 1997-11-20 | The University Of Sheffield | Isopentenyl pyrophosphate isomerase (ipi) and/or prenyl transferase inhibitors |
DE19738005A1 (de) | 1997-08-30 | 1999-03-04 | Bayer Ag | Verwendung von substituierten 1,1-Bisphosphonaten |
DE19828450A1 (de) | 1998-06-26 | 1999-12-30 | Hassan Jomaa | Bisphosphonsäuren und deren Derivate enthaltende Arzneimittel zur Prophylaxe und zur Behandlung von Autoimmunkrankheiten sowie von Allergien |
WO2000001238A1 (en) * | 1998-07-06 | 2000-01-13 | Kajander E Olavi | Methods for eradication of nanobacteria |
US5998390A (en) * | 1998-09-28 | 1999-12-07 | The Research Foundation Of State University Of New York | Combination of bisphosphonate and tetracycline |
-
1999
- 1999-12-23 TR TR2001/01841T patent/TR200101841T2/tr unknown
- 1999-12-23 CZ CZ20012231A patent/CZ20012231A3/cs unknown
- 1999-12-23 CN CN99814903A patent/CN1331597A/zh active Pending
- 1999-12-23 PT PT99964669T patent/PT1140113E/pt unknown
- 1999-12-23 MX MXPA01006473A patent/MXPA01006473A/es unknown
- 1999-12-23 WO PCT/EP1999/010350 patent/WO2000038660A2/de active IP Right Grant
- 1999-12-23 CA CA002356262A patent/CA2356262A1/en not_active Abandoned
- 1999-12-23 AU AU30433/00A patent/AU754862B2/en not_active Ceased
- 1999-12-23 EP EP99964669A patent/EP1140113B1/de not_active Expired - Lifetime
- 1999-12-23 IL IL14346999A patent/IL143469A0/xx unknown
- 1999-12-23 BR BR9916850-2A patent/BR9916850A/pt not_active Application Discontinuation
- 1999-12-23 US US09/868,961 patent/US6696427B1/en not_active Expired - Fee Related
- 1999-12-23 JP JP2000590614A patent/JP2002533385A/ja active Pending
- 1999-12-23 DK DK99964669T patent/DK1140113T3/da active
- 1999-12-23 AT AT99964669T patent/ATE253368T1/de not_active IP Right Cessation
- 1999-12-23 ES ES99964669T patent/ES2205930T3/es not_active Expired - Lifetime
- 1999-12-23 PL PL99349438A patent/PL349438A1/xx not_active Application Discontinuation
-
2001
- 2001-05-30 IS IS5956A patent/IS5956A/is unknown
- 2001-06-22 NO NO20013167A patent/NO20013167L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1140113A2 (de) | 2001-10-10 |
CA2356262A1 (en) | 2000-07-06 |
WO2000038660A2 (de) | 2000-07-06 |
AU754862B2 (en) | 2002-11-28 |
IL143469A0 (en) | 2002-04-21 |
PL349438A1 (en) | 2002-07-29 |
ES2205930T3 (es) | 2004-05-01 |
EP1140113B1 (de) | 2003-11-05 |
PT1140113E (pt) | 2004-03-31 |
CZ20012231A3 (cs) | 2001-09-12 |
BR9916850A (pt) | 2001-10-16 |
NO20013167D0 (no) | 2001-06-22 |
DK1140113T3 (da) | 2004-02-16 |
IS5956A (is) | 2001-05-30 |
WO2000038660A3 (de) | 2000-12-21 |
CN1331597A (zh) | 2002-01-16 |
AU3043300A (en) | 2000-07-31 |
NO20013167L (no) | 2001-06-22 |
US6696427B1 (en) | 2004-02-24 |
ATE253368T1 (de) | 2003-11-15 |
MXPA01006473A (es) | 2002-04-24 |
JP2002533385A (ja) | 2002-10-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2000001942A0 (en) | Use of organophosphoric compounds for the therapeutic and preventative treatment of infections. | |
ATE295355T1 (de) | Trisubstituierte 1,3,5-triazine derivate zur behandlung von hiv infektionen | |
ES2160046A1 (es) | Derivados pentapeptidicos. | |
MXPA04012965A (es) | Inhibidores virales. | |
ID21526A (id) | 4-hidroksiquinolin-3-karboksamida dan hidrazida sebagai bahan anti-virus | |
DE60214179D1 (de) | IMIDAZOi1,2-AöPYRIDIN-DERIVATE ZUR PROPHYLAXE UND BEHANDLUNG VON HERPES-INFEKTIONEN | |
BRPI0418251A (pt) | fosfonatos, monofosfonamidatos, bisfosfonamidatos para o tratamento de doenças virais | |
ATE298741T1 (de) | Polyaromatische verbindungen zur behandlung von herpes-infektionen | |
DE60211539D1 (de) | Imidazopyridinderivate zur verwendung bei der behandlung von herpes-vireninfektion | |
TR200101841T2 (tr) | Enfeksiyonlardan korunmak ve enfeksiyon tedavisi için bifosfonatların kullanılmaları | |
ATE335499T1 (de) | Zusammensetzungen zur behandlung von staphylococcus aureus infektionen | |
ATE486634T1 (de) | Caspase 3, 8, 9 oder 10 inhibitoren in kombination mit mek inhibitoren zur behandlung von influenza | |
DE60115466D1 (de) | Wirkstoffvorläufer von imidazopyridin-derivaten | |
AP2001002106A0 (en) | Use of organophosphorus compounds for producing medicaments for the therapeutic and prophylactic treatment of infections or as a fungicide, bactericide or herbicide. | |
BR9915639A (pt) | Uso de derivados de ácido fosfonofórmico para o tratamento de infecções | |
NO20013651L (no) | Anvendelse av fosfororganiske forbindelser for profylaktisk og terapeutisk behandling av infeksjoner | |
DE69838980D1 (de) | Kombination von product r mit einem antiviralen mittel in der behandlung von hiv infektionen | |
BR9915605A (pt) | Uso de derivados do ácido fosfonofórmico para o tratamento de infecções | |
EA200001065A1 (ru) | Применение фосфорорганических соединений для терапевтического и профилактического лечения инфекций | |
EA200100768A1 (ru) | Применение 3-изоксазолидинонов и гидроксиаминокислот для лечения инфекций | |
BR0007491A (pt) | Uso de 3-isoxazolidinonas e ácidos hidroxilâmicospara o tratamento de infecções | |
ATE113843T1 (de) | Verwendung eines prolylendopeptidase-inhibitors zur behandlung von aids. | |
ECSP972314A (es) | Derivados de aminoacidos | |
MX9400210A (es) | Tratamiento de infecciones virales. |